The companies objected. So did the DEA. But a federal appeals court liberated the ARCOS opioid data.
View original article
Contributor: Joel Achenbach
The companies objected. So did the DEA. But a federal appeals court liberated the ARCOS opioid data.
View original article
Contributor: Joel Achenbach